Smoore 2024 Interim Financial Report: 71.9% Growth in Proprietary Brand Business, 12.3% Decline in Corporate Client Revenue

Business by 2FIRSTS.ai

Aug.20.2024

Smoore International Holdings Ltd. reports a 1.7% decrease in sales revenue compared to the previous year.

On August 19, Smoore International Holdings Limited released its interim financial report for the six-month period ending on June 30, 2024.

Smoore first half financial summary | Image source: Smoore official website screenshot

According to the announcement, the group achieved sales revenue of approximately RMB 5,037,242 thousand during the review period, a decrease of about 1.7% compared to the previous year. Among these, sales revenue from the group's own brand business was approximately RMB 1,115,607 thousand, an increase of about 71.9% year-on-year, with the proportion of total revenue increasing from around 12.7% in the same period last year to about 22.1% in the review period. Sales revenue from enterprise customers was approximately RMB 3,921,635 thousand, a decrease of about 12.3% year-on-year, with the proportion of total revenue decreasing from around 87.3% in the same period last year to about 77.9% in the review period.

References:

[1] 思摩尔国际控股有限公司截至2024年6月30日止 6個月中期業績公告

Also Read:

[1] Smoore International Supplies 10 Products to NJOY LLC

[2] Smoore Stock Price Surges after FDA Approves NJOY's Menthol E-Cigarettes

[3] Smoore International Announces Successful Release of Pledged Shares

[4] Smoore Technology's CCELL Launches New Mini Tank and Atom

[5] Smoore International Announces Financial Data for Quarter Ended March

[6] Smoore's 2023 Annual Performance: Strong Growth and Global Expansion

#Asia #China #Disposable e-cigarettes

We welcome news tips, article submissions, interview requests, or comments on this piece.

Please contact us at info@2firsts.com, or reach out to Alan Zhao, CEO of 2Firsts, on LinkedIn

Notice

1. This article is intended solely for professional research purposes related to industry, technology, and policy. Any references to brands or products are made purely for objective description and do not constitute any form of endorsement, recommendation, or promotion by 2Firsts.

2. The use of nicotine-containing products — including, but not limited to, cigarettes, e-cigarettes, nicotine pouchand heated tobacco products — carries significant health risks. Users are responsible for complying with all applicable laws and regulations in their respective jurisdictions.

3. This article is not intended to serve as the basis for any investment decisions or financial advice. 2Firsts assumes no direct or indirect liability for any inaccuracies or errors in the content.

4. Access to this article is strictly prohibited for individuals below the legal age in their jurisdiction.

Copyright

This article is either an original work created by 2Firsts or a reproduction from third-party sources with proper attribution. All copyrights and usage rights belong to 2Firsts or the original content provider. Unauthorized reproduction, distribution, or any other form of unauthorized use by any individual or organization is strictly prohibited. Violators will be held legally accountable.

For copyright-related inquiries, please contact: info@2firsts.com

AI Assistance Disclaimer

This article may have been enhanced using AI tools to improve translation and editorial efficiency. However, due to technical limitations, inaccuracies may occur. Readers are encouraged to refer to the cited sources for the most accurate information.

We welcome any corrections or feedback. Please contact us at: info@2firsts.com

Indonesian Police to Crack Down on Etomidate-Laced Vapes

Indonesia’s National Police Criminal Investigation Department (Bareskrim Polri) will continue to take enforcement action against users and distributors of etomidate-laced vape liquids, even though the substance is not yet classified as a narcotic. Brigadier General Eko Hadi Santoso, Director of Narcotics Crimes, said etomidate is an anaesthetic drug regulated under Health Law No. 17 of 2023, but has not been listed as a narcotic or psychotropic substance.

Oct.23 by 2FIRSTS.ai

Special Report | Anti-Vaping Campaign in the Baltics Goes Sideways

2Firsts analyzes vaping regulations across the Baltic states. Following Latvia’s flavor ban, tax revenues fell and the black market expanded, while similar measures in Estonia and Lithuania have also failed to deliver results. The region’s anti-vaping policies are now triggering market imbalance and policy reassessment.

Oct.13

2Firsts Insights | From Limited-Edition Frenzy to Interactive Lead-Gen: The 2025 Halloween Shift in Vape Marketing

For Halloween 2025, leading vape brands such as HQD and ELFBAR are running overseas social-media engagement campaigns—covering points programs and UGC giveaways with age/region restrictions. Unlike 2024’s wave of themed devices, no brand-new Halloween limited editions have appeared on major U.S. channels this year; only RAZ has restocked last year’s version.

Oct.31 by 2FIRSTS.ai

Singapore's Bishan MRT station security officers apprehended a man who discarded an e-cigarette, as crackdown efforts intensify

Security officers at Bishan MRT station in Singapore apprehended a man who evaded security and found his discarded e-cigarette in nearby bushes. The man pleaded guilty to the offence, and the case was referred to the Health Sciences Authority. The incident is part of Singapore's intensified, government-wide crackdown on e-cigarette use.